Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Biotechnologie”
Aandelen in “Biotechnologie”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Biotechnologie”
Toon enkel gratis nieuws
07:00 ·
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
· Persbericht
07:00 ·
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
· Persbericht
20/05 ·
Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session
· Persbericht
20/05 ·
Anna Richo joins Illumina's Board of Directors
· Persbericht
20/05 ·
Soligenix Encourages Stockholders to Vote Prior to Annual Meeting
· Persbericht
20/05 ·
Compugen Reports First Quarter 2024 Results
· Persbericht
20/05 ·
PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation
· Persbericht
20/05 ·
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn
· Persbericht
20/05 ·
Pharming Group to participate in May investor conference
· Persbericht
19/05 ·
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
· Persbericht
17/05 ·
DBV Technologies Announces Plan to Implement ADS Ratio Change
· Persbericht
17/05 ·
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
· Persbericht
17/05 ·
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
· Persbericht
16/05 ·
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
· Persbericht
16/05 ·
Monthly information on share capital and company voting rights
· Persbericht
16/05 ·
DBV Technologies Announces Results of its 2024 Combined General Meeting
· Persbericht
16/05 ·
Voting Rights and Shares Capital of the Company
· Persbericht
16/05 ·
Galapagos creates new subscription right plans
· Persbericht
16/05 ·
Galapagos creëert nieuwe inschrijvingsrechtenplannen
· Persbericht
16/05 ·
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
· Persbericht
16/05 ·
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe